These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 15147526)

  • 61. [Fabry disease in childhood].
    Chabrol B; Mansour H; Cano A
    Presse Med; 2007 Mar; 36 Spec No 1():1S32-5. PubMed ID: 17546765
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Anderson-Fabry disease: enzyme replacement therapy.
    Leon-Mateos A; Fernández-Redondo V; Beiras A; Toribio J
    Acta Derm Venereol; 2004; 84(1):88-9. PubMed ID: 15040494
    [No Abstract]   [Full Text] [Related]  

  • 63. Fabry disease mimicking multiple sclerosis.
    Saip S; Uluduz D; Erkol G
    Clin Neurol Neurosurg; 2007 May; 109(4):361-3. PubMed ID: 17234336
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Fabry disease (alpha-galactosidase A deficiency): renal involvement and enzyme replacement therapy.
    Desnick RJ; Wasserstein MP; Banikazemi M
    Contrib Nephrol; 2001; (136):174-92. PubMed ID: 11688379
    [No Abstract]   [Full Text] [Related]  

  • 65. Non-specific gastrointestinal features: Could it be Fabry disease?
    Hilz MJ; Arbustini E; Dagna L; Gasbarrini A; Goizet C; Lacombe D; Liguori R; Manna R; Politei J; Spada M; Burlina A
    Dig Liver Dis; 2018 May; 50(5):429-437. PubMed ID: 29602572
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Rare diseases in Croatia--lesson learned from Anderson-Fabry disease.
    Mrsić M; Nola M
    Croat Med J; 2008 Oct; 49(5):579-81. PubMed ID: 18925690
    [No Abstract]   [Full Text] [Related]  

  • 67. Pathological findings in a patient with Fabry disease who died after 2.5 years of enzyme replacement.
    Schiffmann R; Rapkiewicz A; Abu-Asab M; Ries M; Askari H; Tsokos M; Quezado M
    Virchows Arch; 2006 Mar; 448(3):337-43. PubMed ID: 16315019
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Fabry disease in the era of enzyme replacement therapy: a renal perspective.
    Cho ME; Kopp JB
    Pediatr Nephrol; 2004 Jun; 19(6):583-93. PubMed ID: 15064943
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Cardiac involvement in Fabry disease.
    Linhart A; Magage S; Palecek T; Bultas J
    Acta Paediatr Suppl; 2002; 91(439):15-20. PubMed ID: 12572837
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [What is new in Fabry disease?].
    Lidove O
    Rev Med Interne; 2007 Dec; 28 Suppl 4():S296-7. PubMed ID: 17964003
    [No Abstract]   [Full Text] [Related]  

  • 71. [The nephropathy in the Anderson-Fabry disease: new recommendations for the diagnosis, the follow-up and the therapy].
    Mignani R; Gallieni M; Feriozzi S; Pisani A; Marziliano N; Morrone A
    G Ital Nefrol; 2015; 32(4):. PubMed ID: 26252265
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Guidelines for diagnosis, therapy and follow up of Anderson-Fabry disease].
    Kes VB; Cesarik M; Zavoreo I; Butković SS; Kes P; Bašić-Jukić N; Rački S; Jakić M; Delić-Brkljačić D; Jukić Z; Trkanjec Z; Šerić V; Solter VV; Bielen I; Bašić S; Demarin V; ; ; ;
    Acta Med Croatica; 2014 Apr; 68(2):223-32. PubMed ID: 26012164
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Functional renal investigation in Fabry disease].
    Froissart M; Benistan K; Germain DP
    Presse Med; 2007 Mar; 36 Spec No 1():1S36-42. PubMed ID: 17546766
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Diagnosis of cardiovascular involvement in Fabry disease].
    Citro R; Cristiano M; Radano I; Bellino M; Caiazza M; Galasso G; Limongelli G
    G Ital Cardiol (Rome); 2023 Jan; 24(1):19-29. PubMed ID: 36573506
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Morbus Fabry of the heart. Why should cardiologists care?
    Strotmann J; Weidemann F; Breunig F; Knoll A; Wanner C; Ertl G
    Z Kardiol; 2005 Sep; 94(9):557-63. PubMed ID: 16142514
    [TBL] [Abstract][Full Text] [Related]  

  • 76. A 14-year-old boy with pain in hands and feet.
    Charrow J
    Pediatr Ann; 2009 Apr; 38(4):190, 192. PubMed ID: 19455947
    [No Abstract]   [Full Text] [Related]  

  • 77. New developments in the management of Anderson-Fabry disease.
    Mehta A
    QJM; 2002 Oct; 95(10):647-53. PubMed ID: 12324636
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Fabry disease: progression of nephropathy, and prevalence of cardiac and cerebrovascular events before enzyme replacement therapy.
    Schiffmann R; Warnock DG; Banikazemi M; Bultas J; Linthorst GE; Packman S; Sorensen SA; Wilcox WR; Desnick RJ
    Nephrol Dial Transplant; 2009 Jul; 24(7):2102-11. PubMed ID: 19218538
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Imaging features of Fabry disease.
    Lidove O; Klein I; Lelièvre JD; Lavallée P; Serfaty JM; Dupuis E; Papo T; Laissy JP
    AJR Am J Roentgenol; 2006 Apr; 186(4):1184-91. PubMed ID: 16554602
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Diagnostic challenges and new therapies for rare lysosomal storage diseases.
    Hesselgrave B
    Case Manager; 2003; 14(6):48-52. PubMed ID: 14618149
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.